The ₹74 Crore Profit That Lost 22% in Five Days

Q2 delivered a strong operational recovery — PAT nearly tripled, EBITDA margins expanded 220 basis points, and the company cut net debt by ₹261 crore. Yet the stock fell 22% in five trading days after the result. The disconnect is worth parsing: the quarter is genuinely strong, but H1 as a whole is still down 9.7% YoY, and the market is pricing in execution risk on a ₹200 crore specialty capex bet that won't deliver revenue until FY28.

The PAT spike from ₹24.6 crore (Q2 FY26) to ₹74.1 crore is not a one-time accounting surprise — it reflects genuine operational progress. EBITDA jumped ₹50 crore YoY to ₹117.7 crore (8.8% margin), driven by margin expansion, not just volume recovery. Management held costs steady while pricing improved thanks to better product mix and PTA supply stabilization. Finance costs fell ₹4.6 crore H1 due to debt paydown. The profit quality is solid; the catch is that this recovery started from a deeply depressed Q2 FY26 (supply chain had crippled the prior year).

EBITDA margin trajectory shifted up. Q2 margin of 8.8% vs 6.6% in Q2 FY26 (+220 bps) contradicts prior expectations that new capacity would pressure margins. Instead, operational leverage and product mix improvements drove expansion. Debt reduction accelerated. Net debt fell ₹261 crore H1 to ₹852 crore (a 23.5% reduction from FY26 end). Supply chain narrative pivoted. H1 bore the full weight (−9.7% revenue), but Q2 rebounded (+10%), signaling stabilization rather than prolonged disruption. Competitive outlook upgraded. Chinese polyester facing currency headwinds (INR 12 vs CNY to INR 14.5 now) and exiting commodity business. Anti-dumping duty on PTA/MEG now in force, protecting domestic margins.

The selloff is not a rejection of Q2 — the quarter delivered what was promised. It is a repricing of three things: First, H1 revenue is still down 9.7% YoY, meaning the 'recovery' narrative is incomplete until volumes stabilize above prior-year. Second, management guided to 9.9% EBITDA margins 'maintained' — not expanded — signaling confidence is cautious, not bullish. Third, the ₹200 crore specialty capex, which carries 3–4 year execution risk and won't deliver revenue until FY28, is being discounted as speculative by a market that wants near-term growth. Add a falling rupee (INR 12 → INR 14.5 vs CNY), geopolitical freight risk, and a 35% drawdown from all-time highs, and the risk/reward shifted against holders.

The post-result price action is the street's own verdict: day 1 saw a -5.45% decline (normal post-result volatility), but by day 3 the stock was down -21.59% and by day 5 the selling held at -22.62%. This is not a technical blip — it is a repricing. The stock is now 35.4% below its all-time high of ₹112.28 and trading below its 20-day and 50-day moving averages (₹86.58 and ₹82.7 respectively). RSI at 36.1 signals oversold conditions. Institutional positioning has shifted: FII ownership has fallen from 0.50% (Q1 FY26) to 0.13% (Q1 FY27), a sustained trimming over six quarters. DII ownership is stable at 0.92%, and promoter Indorama remains locked at 74.84%. The FII exit suggests large foreign investors saw the specialty capex narrative and execution risk, and decided the risk/reward no longer justified a hold. Promoter lock-in combined with FII exodus signals insider confidence is weaker than guided tone suggests.